U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07293715) titled 'Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)' on Dec. 02.
Brief Summary: PRISM-TID is a single center non-inferiority randomized controlled trial of permissive intrapartum glucose management (intervention) versus strict intrapartum glucose management (standard of care) among pregnant individuals with type 1 diabetes (T1D) using hybrid closed loop therapy (HCL) who are admitted for labor management. Participants will be randomized in a 1:1 fashion to one of two intrapartum glycemic control options: permissive (70-140 mg/dL) or strict (70-110 mg/dL). The primary aim of this trial it to demonst...